Associate CMO Boston MedFlight Boston, Massachusetts, United States
Disclosure(s):
Susan R. Wilcox, MD, FCCM, FACEP, FAAEM: No financial relationships to disclose
In most patients, intubation and initiation of ventilation are sufficient to treat respiratory failure. Patients with refractory hypoxemia in transport, however, are very difficult to manage. Ventilator optimization, the evolving role of neuromuscular blockade, the use of proning in transport, and inhaled pulmonary vasodilators will be covered. Additionally, considerations for VV ECMO will also be addressed.
Learning Objectives:
Review the pathophysiology of severe hypoxemia, including shunting and derecruitment
Discuss the data for adjunctive therapies, including neuromuscular blockade, proning, and inhaled pulmonary vasodilators
Review indications for VV ECMO referrals and transports